Clobazam (Onfi)

ORAL ADMINISTRATION

Indications for Prior Authorization:

  • Indiated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older

Patients must meet the following criteria for the indication(s) above:

  • Prescribed by or in collaboration with a neurologist, AND
  • 2 years of age or older, AND
  • Diagnosis of Lennox-Gastaut syndrome, AND
  • Currently receiving treatment with at least one other antiepileptic medication

Dosing:

  • Dose patients according to body weight.  Individualize dosing within each body weight group, based on clinical efficacy and tolerability.
  Less than or equal to 30 kg Body Weight Greater than 30 kg Body weight
Starting Dose 5 mg 10 mg
Starting Day 7 10 mg 20 mg
Starting Day 14 20 mg 40 mg

 

 

 

 

 

  • Administer tablets whole, broken in half along the score, or crushed and mixed in applesauce.
  • To discontinue, taper by decreasing the total daily dose by 5-10 mg/day on a weekly basis until discontinued.

Approval:

  • 1 year

Last review date: June 12, 2017

The site you are transferring to is not hosted by WHA. WHA's Terms of Use and internet Privacy Practices do not apply to your use of this linked site. Please review the policies on privacy and terms of use for the linked site. WHA does not control the accuracy, completeness, or timeliness of the content on the linked site.

Press Esc to cancel

El sitio Web al que está siendo transferido no es provisto por WHA. Las Condiciones de Uso y las Prácticas de Privacidad en Internet de WHA no se aplican a este sitio Web asociado que usted está usando. Revise las políticas sobre la privacidad y condiciones de uso de este sitio Web asociado. WHA no tiene control sobre la exactitud, la totalidad o la actualidad del contenido del sitio Web asociado. WHA no puede garantizar que los servicios de traducción de idiomas estarán disponibles en el sitio vinculado.

Presione «Esc» para cancelar